A simple lesson before discharge could ease the heavy load on family caregivers

NCT ID NCT07078188

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether giving caregivers of palliative care patients a single training session on using a PEG feeding tube before the patient leaves the hospital can lower the caregivers' burden, stress, and improve their quality of life. Researchers will compare trained caregivers to those who receive no such training, measuring outcomes at 1 and 3 months. The goal is to see if this simple educational step can make a real difference for families.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PEG training (a behavioral intervention teaching caregivers how to use a feeding tube)
What this could lead to
If effective, this training could become a standard practice to ease the emotional and physical strain on family caregivers of palliative care patients.
What could go wrong
This is a small, single-center study with 62 participants, so results may not apply broadly. The training is brief (one session), which may not be enough to produce lasting benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAREGIVER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Caregiver Burden stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Üsküdar State Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.